BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Caenepeel C, Sadat Seyed Tabib N, Vieira-Silva S, Vermeire S. Review article: how the intestinal microbiota may reflect disease activity and influence therapeutic outcome in inflammatory bowel disease. Aliment Pharmacol Ther 2020;52:1453-68. [PMID: 32969507 DOI: 10.1111/apt.16096] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 3.5] [Reference Citation Analysis]
Number Citing Articles
1 Pu D, Zhang Z, Feng B. Alterations and Potential Applications of Gut Microbiota in Biological Therapy for Inflammatory Bowel Diseases. Front Pharmacol 2022;13:906419. [DOI: 10.3389/fphar.2022.906419] [Reference Citation Analysis]
2 Antunes JC, Seabra CL, Domingues JM, Teixeira MO, Nunes C, Costa-Lima SA, Homem NC, Reis S, Amorim MTP, Felgueiras HP. Drug Targeting of Inflammatory Bowel Diseases by Biomolecules. Nanomaterials (Basel) 2021;11:2035. [PMID: 34443866 DOI: 10.3390/nano11082035] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
3 Fairbrass KM, Gracie DJ, Ford AC. Longitudinal follow-up study: effect of psychological co-morbidity on the prognosis of inflammatory bowel disease. Aliment Pharmacol Ther 2021;54:441-50. [PMID: 34114664 DOI: 10.1111/apt.16454] [Reference Citation Analysis]
4 Kim KU, Kim J, Kim WH, Min H, Choi CH. Treatments of inflammatory bowel disease toward personalized medicine. Arch Pharm Res 2021;44:293-309. [PMID: 33763844 DOI: 10.1007/s12272-021-01318-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
5 Mayne J, Zhang X, Butcher J, Walker K, Ning Z, Wójcik E, Dastych J, Stintzi A, Figeys D. Examining the Effects of an Anti-Salmonella Bacteriophage Preparation, BAFASAL®, on Ex-Vivo Human Gut Microbiome Composition and Function Using a Multi-Omics Approach. Viruses 2021;13:1734. [PMID: 34578313 DOI: 10.3390/v13091734] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Li S, Yang S, Zhang Y, Huang K, Liang T, Chen Y, Guan Y, Shang R, Guan T, Wu J, Chen Y, Guan X. Amino acid-balanced diets improved DSS-induced colitis by alleviating inflammation and regulating gut microbiota. Eur J Nutr 2022. [PMID: 35618921 DOI: 10.1007/s00394-022-02906-y] [Reference Citation Analysis]
7 Thomson P, Núñez P, Quera R, Bay C. Gastrointestinal microbiome, what is behind faecal microbiota transplantation? New Microbes New Infect 2021;42:100898. [PMID: 34168881 DOI: 10.1016/j.nmni.2021.100898] [Reference Citation Analysis]
8 Weidinger C, Krug SM, Voskens C, Moschen AR, Atreya I. Editorial: Loss of Epithelial Barrier Integrity in Inflammatory Diseases: Cellular Mediators and Therapeutic Targets. Front Med (Lausanne) 2021;8:813153. [PMID: 34957170 DOI: 10.3389/fmed.2021.813153] [Reference Citation Analysis]
9 Wan F, Zhong R, Wang M, Zhou Y, Chen Y, Yi B, Hou F, Liu L, Zhao Y, Chen L, Zhang H. Caffeic Acid Supplement Alleviates Colonic Inflammation and Oxidative Stress Potentially Through Improved Gut Microbiota Community in Mice. Front Microbiol 2021;12:784211. [PMID: 34867926 DOI: 10.3389/fmicb.2021.784211] [Reference Citation Analysis]
10 Howden CW, Loomba R. A Message from the Editors. Aliment Pharmacol Ther 2022;55:4-5. [PMID: 34907571 DOI: 10.1111/apt.16701] [Reference Citation Analysis]
11 Klichowska-Palonka M, Komsta A, Pac-Kożuchowska E. The condition of the oral cavity at the time of diagnosis of inflammatory bowel disease in pediatric patients. Sci Rep 2021;11:21898. [PMID: 34753969 DOI: 10.1038/s41598-021-01370-8] [Reference Citation Analysis]
12 Chen Y, Cui W, Li X, Yang H. Interaction Between Commensal Bacteria, Immune Response and the Intestinal Barrier in Inflammatory Bowel Disease. Front Immunol 2021;12:761981. [PMID: 34858414 DOI: 10.3389/fimmu.2021.761981] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 Gutiérrez A, Rodríguez-Lago I. How to Optimize Treatment With Ustekinumab in Inflammatory Bowel Disease: Lessons Learned From Clinical Trials and Real-World Data. Front Med (Lausanne) 2021;8:640813. [PMID: 33585530 DOI: 10.3389/fmed.2021.640813] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
14 Wu Y, Wu Y, Wu H, Wu C, Ji E, Xu J, Zhang Y, Wei J, Zhao Y, Yang H. Systematic Survey of the Alteration of the Faecal Microbiota in Rats With Gastrointestinal Disorder and Modulation by Multicomponent Drugs. Front Pharmacol 2021;12:670335. [PMID: 34803663 DOI: 10.3389/fphar.2021.670335] [Reference Citation Analysis]